Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action. (2018)
Attributed to:
MICA: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/gme.0000000000001090
PubMed Identifier: 29533369
Publication URI: http://europepmc.org/abstract/MED/29533369
Type: Journal Article/Review
Volume: 25
Parent Publication: Menopause (New York, N.Y.)
Issue: 8
ISSN: 1072-3714